# AT-301 Nasal Spray in Healthy Adults

> **NCT04519788** · PHASE1 · COMPLETED · sponsor: **Atossa Therapeutics, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AT-301B
- **DRUG:** AT-301A

## Key facts

- **NCT ID:** NCT04519788
- **Lead sponsor:** Atossa Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-07
- **Primary completion:** 2020-12-08
- **Final completion:** 2021-01-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04519788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04519788, "AT-301 Nasal Spray in Healthy Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04519788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*